• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1125225-12
Device Problems Peeled/Delaminated (1454); Product Quality Problem (1506); Failure to Advance (2524)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/02/2016
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The device was received.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
 
Event Description
It was reported that after pre-dilating a mildly calcified, concentric, 75% stenosed 10-mm-long lesion in the moderately tortuous 2.25mm diameter distal circumflex coronary artery with a 2.0mm non-abbott balloon catheter, a 2.25x12 xience alpine stent delivery system (sds) was advanced without force applied, but failed to cross the lesion due to patient anatomy.In order to perform additional dilatation with a balloon, the xience alpine was withdrawn from the anatomy, without resistance, when it was noted that there was shredding and flaring of the balloon material at the proximal part of the balloon.While no damage was noted to the stent struts and the stent remained firmly crimped on the balloon, the xience alpine was not used to complete the procedure due to the balloon shredding/flaring.Reportedly, the shredded balloon did not appear to have detached from the balloon inside of patient anatomy.Another 2.25x12 xience alpine sds was able to cross the lesion successfully and was deployed without issue, completing the procedure.There was no occurrence of a clinically significant delay and no adverse patient effects.No additional information was provided.
 
Manufacturer Narrative
(b)(4).Evaluation summary: the device was returned for analysis; however, there was no balloon material shredding and flaring noted at the proximal part of the balloon as reported but there was a foreign material on the proximal part of the balloon for a length of 2 mm confirming the reported unusual appearance.Additional follow-up confirmed that the correct complaint device had been returned and that the unidentified material is likely what was thought to be flared/peeled/shredded (balloon) material.A chemical analysis showed that the unidentified material to resemble hemoglobin and human skin.The reported unusual appearance was able to be confirmed.The reported failure to advance the device was unable to be replicated in a testing environment as it was based on operational circumstances.The investigation determined the reported difficulties appear to be related to circumstances of the procedure.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key5749536
MDR Text Key48350580
Report Number2024168-2016-04129
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 08/02/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/25/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/10/2018
Device Catalogue Number1125225-12
Device Lot Number5022361
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer06/17/2016
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/28/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-